InvestorsHub Logo
Followers 134
Posts 3749
Boards Moderated 0
Alias Born 01/28/2006

Re: TheDane post# 330695

Saturday, 10/31/2020 1:52:47 PM

Saturday, October 31, 2020 1:52:47 PM

Post# of 403092
The fact the RBL is planning on developing an inhaler shows how much confidence they have in Brilacidin being approved as a Covid19 drug.

I am surprised they mentioned the inhaler at this stage and assumed they would not begin work on it until Brilacidin was approved as a new drug. Getting started on the inhaler now will move development up months may be years.

IPIX is not the only company developing an inhaler for Covid19. Hydroxychloroquine is being studied as an inhaler as are several corticosteroids.

https://www.clinicaltrials.gov/ct2/results?cond=covid19&term=inhaled+drug%3B+inhaler&cntry=&state=&city=&dist=

Remdesivir and interferon are being studied as an inhalers and a HDP is also being studied.

https://www.fiercepharma.com/pharma/gilead-kicks-off-clinical-trial-inhaled-remdesivir-for-less-severe-covid-19

https://www.washingtonpost.com/science/2020/08/31/interferons-coronavirus-immune-boost/

I read earlier a HDP was being studied as a Covid19 inhaler but I could not find the link.

GLTA, Farrell
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News